Type 2 diabetes with good glycemic control have improved insulin response and lower non-esterified fatty acid level after a meal challenge
- 1 Endocrine Unit, Department of Medicine, Universiti Sains Malaysia, Penang, Malaysia
- 2
- 3
- 4
Abstract
Background: Pathogenesis of type 2 diabetes (T2DM) involves defects in β-cell function with impaired first and second phase insulin response, and reduced insulin sensitivity. Diabetic dyslipidemia is an important and common risk factor for coronary heart disease (CHD). Aims: This study examined the effect of glycemic control on post prandial insulin and lipid parameters in response to a standardised meal challenge among Type 2 diabetes patients with good and poor glycemic control. Methods: We cross-sectionally studied 31 T2DM patients with good glycemic control and 32 T2DM patients with poor glycemic control. Subjects were given, after minimum 10 hours of fasting, a standard meal containing 58% fat. Fasting and serial postprandial blood samples were taken over 8 hours to determine levels of triglyceride, direct LDL-C, apoB lipoprotein, non-esterified-fatty-acid, insulin and blood glucose. Results: Post prandial NEFA was significantly higher in poor controlled diabetes patients compared to good control diabetes patients (p = 0.019), and post-hoc analysis showed significant difference from 3 hours post prandial to 4 hours post prandial, where p= 0.021. Although the difference in insulin between the 2 groups did not reach statistical significance (p =0.058), post-hoc analysis showed significant difference between the 2 groups from fasting to 1 hour post prandial (p = 0.034) despite postprandial glucose being significantly higher in poor controlled diabetes patients (p < 0.001), throughout the postprandial period. Conclusion: T2DM patients with good glycemic control have improved insulin response with lower non-esterified fatty acid.
- Taskinen, M.R. (2003) Diabetic dyslipidaemia: From basic research to clinical practice. Diabetologia, 46, 733-749. doi:10.1007/s00125-003-1111-y
- Lowe, L.P., Liu, K., Greenland, P. et al. (1997) Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: The Chicago heart association detection project in industry study. Diabetes Care, 20, 163-169. doi:10.2337/diacare.20.2.163
- The DECODE Study Group, the European Diabetes Epidemiology Group. (1999) Glucose tolerance and mortality: Comparison of WHO and ADA diagnostic criteria. Lancet, 354, 617-621. doi:10.1016/S0140-6736(98)12131-1
- Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A. and Laakso, M. (2003) The STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM Trial. Journal of the American Medical Association (JAMA), 290, 486-494. doi:10.1001/jama.290.4.486
- Bansal, S., Buring, J.E., Rifai, N., Mora, S., Sacks, F.M. and Ridker, P.M. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of the American Medical Association (JAMA), 298, 309-316. doi:10.1001/jama.298.3.309
- Nordestgaard, B.G., Benn, M., Schnohr, P. and Tybjaerg-Hansen, A. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischaemic heart disease, and death in men and women. Journal of the American Medical Association (JAMA), 298, 299-308. doi:10.1001/jama.298.3.299
- Phillips, C., Murugasu, G., Owens, D., Collins, P., Johnson, A. and Tomkin, G.H. (2000) Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes. Atherosclerosis, 148, 283-291. doi:10.1016/S0021-9150(99)00275-0
- Turner, R.C., Cull, C.A., Frighi, V. and Holman, R.R. (1999) Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. Journal of the American Medical Association (JAMA), 281, 2005-2012. doi:10.1001/jama.281.21.2005
- Matthews, D.R., Cull, R.A., Stratton, I.M., Holman, R.R. and Turner, R.C. (1998) UKPDS 26: Sulfonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabetic Medicine, 15, 297-303. doi:10.1002/(SICI)1096-9136(199804)15:4 3.3.CO;2-N